Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA/FSL

BackgroundMeasurements of brain volume loss (BVL) in individual patients are currently discussed controversially. One concern is the impact of short-term biological noise, like hydration status.MethodsThree publicly available reliability MRI datasets with scan intervals of days to weeks were used. An additional cohort of 60 early relapsing multiple sclerosis (MS) patients with MRI follow-ups was analyzed to test whether after 1 year pathological BVL is detectable in a relevant fraction of MS patients. BVL was determined using SIENA/FSL. Results deviating from zero in the reliability datasets were considered as within-patient fluctuation (WPF) consisting of the intrinsic measurement error as well as the short-term biological fluctuations of brain volumes. We provide an approach to interpret BVL measurements in individual patients taking the WPF into account.ResultsThe estimated standard deviation of BVL measurements from the pooled reliability datasets was 0.28%. For a BVL measurement of x% per year in an individual patient, the true BVL lies with an error probability of 5% in the interval x% ± (1.96 × 0.28)/(scan interval in years)%. To allow a BVL per year of at least 0.4% to be identified after 1 year, the measured BVL needs to exceed 0.94%. The median BVL per year in the MS patient cohort was 0.44%. In 11 out of 60 MS patients (18%) we found a BVL per year equal or greater than 0.94%.ConclusionThe estimated WPF may be helpful when interpreting BVL results on an individual patient level in diseases such as MS.

[1]  K. Schmierer,et al.  Is it time to target no evident disease activity (NEDA) in multiple sclerosis? , 2015, Multiple sclerosis and related disorders.

[2]  L. Jones,et al.  B2 Cell-based assays of CAG repeat instability in the huntingtin (HTT) gene , 2016 .

[3]  Otto W. Witte,et al.  Changes in Brain Size during the Menstrual Cycle , 2011, PloS one.

[4]  Anisha Keshavan,et al.  Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis , 2016, NeuroImage.

[5]  M. Battaglini,et al.  Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  S. Vos,et al.  Reliability of brain volume measurements: A test-retest dataset , 2014, Scientific Data.

[7]  H. Huppertz,et al.  Atlas based brain volumetry: How to distinguish regional volume changes due to biological or physiological effects from inherent noise of the methodology. , 2016, Magnetic resonance imaging.

[8]  Saurabh Jain,et al.  Reliable measurements of brain atrophy in individual patients with multiple sclerosis , 2016, Brain and behavior.

[9]  Mark Jenkinson,et al.  Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis , 2012, NeuroImage.

[10]  M. Sormani,et al.  Estimates of age-dependent cutoffs for pathological brain volume loss using SIENA/FSL—a longitudinal brain volumetry study in healthy adults , 2017, Neurobiology of Aging.

[11]  Nick C. Fox,et al.  Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX , 2007, NeuroImage.

[12]  Ludwig Kappos,et al.  Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis , 2015, Neurology.

[13]  F. Barkhof Brain atrophy measurements should be used to guide therapy monitoring in MS – NO , 2016, Multiple sclerosis.

[14]  D. Arnold,et al.  Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies , 2014, NeuroImage: Clinical.

[15]  D. Chard,et al.  Grey matter pathology in clinically early multiple sclerosis: Evidence from magnetic resonance imaging , 2009, Journal of the Neurological Sciences.

[16]  M. Dwyer,et al.  Brain atrophy measurements should be used to guide therapy monitoring in MS – YES , 2016, Multiple sclerosis.

[17]  W. Heindel,et al.  Dehydration confounds the assessment of brain atrophy , 2005, Neurology.

[18]  Roland Opfer,et al.  Global and regional annual brain volume loss rates in physiological aging , 2017, Journal of Neurology.

[19]  K. Ohtomo,et al.  A longitudinal study of brain volume changes in normal aging. , 2012, European journal of radiology.

[20]  M. Barnett,et al.  Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis , 2017, CNS Drugs.

[21]  F. Barkhof,et al.  The SIENA/FSL whole brain atrophy algorithm is no more reproducible at 3T than 1.5T for Alzheimer׳s disease , 2014, Psychiatry Research: Neuroimaging.

[22]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[23]  John G. Csernansky,et al.  Open Access Series of Imaging Studies (OASIS): Cross-sectional MRI Data in Young, Middle Aged, Nondemented, and Demented Older Adults , 2007, Journal of Cognitive Neuroscience.